Among dengue during pandemic that reactive to SARS-CoV-2 antibodies (N = 9), 50 % of samples were positive for both IgG and IgM dengue antibodies and 33.3 % for either only IgG or IgM. The gene discussed is CD40LG; the disease is dengue disease.